Health Tidings Policy & AcquisitionsRapport Therapeutics Partners with Tenacia to Develop RAP-219 for Neurologi... Rapport Therapeutics Partners with Tenacia to Develop RAP-219 for Neurologi... Read Post »
Health Tidings Policy & AcquisitionsNovo Nordisk Resolves GLP-1 Dispute with Hims & Hers, Expands Access to... Novo Nordisk Resolves GLP-1 Dispute with Hims & Hers, Expands Access to... Read Post »
Health Tidings Policy & AcquisitionsGSK Licenses Linerixibat to Alfasigma in Deal Worth Up to $690 Million GSK Licenses Linerixibat to Alfasigma in Deal Worth Up to $690 Million Read Post »
Health Tidings Policy & AcquisitionsTenaya Therapeutics and Alnylam Collaborate to Discover Genetic Targets for... Tenaya Therapeutics and Alnylam Collaborate to Discover Genetic Targets for... Read Post »
Health Tidings Policy & AcquisitionsServier Acquires Day One Biopharmaceuticals for $2.5 Billion to Bolster Rar... Servier Acquires Day One Biopharmaceuticals for $2.5 Billion to Bolster Rar... Read Post »
Health Tidings Policy & AcquisitionsSanofi Licenses Rovadicitinib from Sino Biopharm in $1.53B Global Deal Sanofi Licenses Rovadicitinib from Sino Biopharm in $1.53B Global Deal Read Post »
Health Tidings Policy & AcquisitionsDuvakitug Gets $400M Boost: Teva’s IBD Pivot with Blackstone Duvakitug Gets $400M Boost: Teva’s IBD Pivot with Blackstone Read Post »
Health Tidings Policy & AcquisitionsGSK Finalizes $2.2B RAPT Buyout: Ozureprubart Eyes Quarterly Dosing for Foo... GSK Finalizes $2.2B RAPT Buyout: Ozureprubart Eyes Quarterly Dosing for Foo... Read Post »
Policy & AcquisitionsUCB Bets Big on ATG-201: $1.1B License Deal with Antengene for B-Cell Autoi... UCB Bets Big on ATG-201: $1.1B License Deal with Antengene for B-Cell Autoi... Read Post »
Policy & AcquisitionsCullgen Joins Gyre in $300M Pact, Boosting Protein Degraders Cullgen Joins Gyre in $300M Pact, Boosting Protein Degraders Read Post »
Health Tidings Policy & AcquisitionsNovartis Finalizes $12B Avidity Buyout for AOC Muscle Tech Novartis Finalizes $12B Avidity Buyout for AOC Muscle Tech Read Post »
Health Tidings Policy & AcquisitionsEarendil Labs Secures $885M WuXiTecan-2 Rights from WuXi XDC Earendil Labs Secures $885M WuXiTecan-2 Rights from WuXi XDC Read Post »
Health Tidings Policy & AcquisitionsExclusive: Boehringer Ingelheim Acquires Sitryx Program in High-Value Autoi... Exclusive: Boehringer Ingelheim Acquires Sitryx Program in High-Value Autoi... Read Post »
Health Tidings Policy & AcquisitionsBeam Therapeutics Advances BEAM-304 for PKU and Pfizer Collaboration Beam Therapeutics Advances BEAM-304 for PKU and Pfizer Collaboration Read Post »
Health Tidings Policy & AcquisitionsNovo Nordisk Partners with Vivtex to Pioneer Oral Biologics for Obesity and... Novo Nordisk Partners with Vivtex to Pioneer Oral Biologics for Obesity and... Read Post »
Health Tidings Policy & AcquisitionsGSK Acquires 35Pharma for $950M to Advance HS235 in Pulmonary Hypertension ... GSK Acquires 35Pharma for $950M to Advance HS235 in Pulmonary Hypertension ... Read Post »
Health Tidings Policy & AcquisitionsAstellas and Vir Biotechnology Unite to Advance VIR-5500, a Next-Gen T-Cell... Astellas and Vir Biotechnology Unite to Advance VIR-5500, a Next-Gen T-Cell... Read Post »
Health Tidings Policy & AcquisitionsOrganon Licenses MIUDELLA®: New Hormone-Free Copper IUD Option Organon Licenses MIUDELLA®: New Hormone-Free Copper IUD Option Read Post »
Clinical Trails Policy & AcquisitionsGilead Snaps Up Arcellx, Eyes Anito-cel Approval in Multiple Myeloma Gilead Snaps Up Arcellx, Eyes Anito-cel Approval in Multiple Myeloma Read Post »
Health Tidings Policy & AcquisitionsNovartis Licenses UNP’s Macrocyclic Peptides in $1.8B CVD Collaborati... Novartis Licenses UNP’s Macrocyclic Peptides in $1.8B CVD Collaborati... Read Post »
Health Tidings Policy & AcquisitionsKidswell Bio and Treehill Launch Kidswell USA to Advance Cell Therapy for C... Kidswell Bio and Treehill Launch Kidswell USA to Advance Cell Therapy for C... Read Post »
Health Tidings Policy & AcquisitionsSanofi Closes Dynavax Deal, Expands Presence in Adult Vaccines Sanofi Closes Dynavax Deal, Expands Presence in Adult Vaccines Read Post »
Health Tidings Policy & AcquisitionsChugai Licenses Araris’ AraLinQ® Platform to Advance Next-Generation ADC... Chugai Licenses Araris’ AraLinQ® Platform to Advance Next-Generation ADC... Read Post »
Policy & Acquisitions ResearchMexico Partners with Moderna to Boost mRNA Manufacturing and Preparedness Mexico Partners with Moderna to Boost mRNA Manufacturing and Preparedness Read Post »
Policy & AcquisitionsLilly’s $2.4 Billion Orna Deal Signals Push into In Vivo CAR-T Therapies Lilly’s $2.4 Billion Orna Deal Signals Push into In Vivo CAR-T Therapies Read Post »
Food Policy & AcquisitionsNo to Artificial Colors, Yes to Natural Alternatives: What the New FDA Poli... No to Artificial Colors, Yes to Natural Alternatives: What the New FDA Poli... Read Post »
Policy & AcquisitionsIllumina Completes Acquisition of SomaLogic Illumina Completes Acquisition of SomaLogic Read Post »
Policy & AcquisitionsAstraZeneca Bets Big on Next-Gen Obesity Drugs With CSPC AstraZeneca Bets Big on Next-Gen Obesity Drugs With CSPC Read Post »
Policy & AcquisitionsModerna Partners with Recordati to Advance mRNA-3927 for Propionic Acidemia Moderna Partners with Recordati to Advance mRNA-3927 for Propionic Acidemia Read Post »
Policy & AcquisitionsUS Officially Exits WHO in January 2026: Funding Cuts, COVID Fallout, and G... US Officially Exits WHO in January 2026: Funding Cuts, COVID Fallout, and G... Read Post »
Policy & AcquisitionsAstraZeneca Commits $15 Billion to China Expansion by 2030, Boosting Cell T... AstraZeneca Commits $15 Billion to China Expansion by 2030, Boosting Cell T... Read Post »
Policy & AcquisitionsSeamless Therapeutics and Eli Lilly Partner to Advance Programmable Gene Ed... Seamless Therapeutics and Eli Lilly Partner to Advance Programmable Gene Ed... Read Post »
Policy & AcquisitionsSimcere Signs EUR 1.058B IBD Deal with Boehringer Ingelheim for SIM0709 Simcere Signs EUR 1.058B IBD Deal with Boehringer Ingelheim for SIM0709 Read Post »
Policy & AcquisitionsPfizer Taps Novavax Matrix-M in New Licensing Deal Pfizer Taps Novavax Matrix-M in New Licensing Deal Read Post »
Policy & AcquisitionsJanux Therapeutics Inks $850M Deal with Bristol Myers Squibb for Tumor-Acti... Janux Therapeutics Inks $850M Deal with Bristol Myers Squibb for Tumor-Acti... Read Post »
Policy & AcquisitionsBristol Myers Squibb and Microsoft Partner to Advance AI-Driven Early Lung ... Bristol Myers Squibb and Microsoft Partner to Advance AI-Driven Early Lung ... Read Post »
Policy & AcquisitionsShionogi Expands Stake in ViiV Healthcare, Simplifying Ownership Structure ... Shionogi Expands Stake in ViiV Healthcare, Simplifying Ownership Structure ... Read Post »
Policy & AcquisitionsNovo Nordisk and Aspect Biosystems Expand Partnership to Develop Curative C... Novo Nordisk and Aspect Biosystems Expand Partnership to Develop Curative C... Read Post »
Policy & AcquisitionsGSK Expands Immunology Portfolio with RAPT Therapeutics Takeover GSK Expands Immunology Portfolio with RAPT Therapeutics Takeover Read Post »
Policy & AcquisitionsFDA, EMA Issue New Guidance on AI Use in Drug Development FDA, EMA Issue New Guidance on AI Use in Drug Development Read Post »
Policy & AcquisitionsNVIDIA and Eli Lilly Bet $1B on AI-Driven Drug Discovery NVIDIA and Eli Lilly Bet $1B on AI-Driven Drug Discovery Read Post »
Policy & AcquisitionsBayer and Soufflé Therapeutics Partner to Develop Heart-Targeted siRNA The... Bayer and Soufflé Therapeutics Partner to Develop Heart-Targeted siRNA The... Read Post »
Policy & AcquisitionsEli Lilly to Acquire Ventyx Biosciences for $1.2B to Expand Oral Inflammati... Eli Lilly to Acquire Ventyx Biosciences for $1.2B to Expand Oral Inflammati... Read Post »
Policy & AcquisitionsFDA Narrows Oversight for Low-Risk Wellness Wearables, Clarifies What Stays... FDA Narrows Oversight for Low-Risk Wellness Wearables, Clarifies What Stays... Read Post »
Policy & AcquisitionsMerck Completes Acquisition of Cidara Therapeutics to Advance Long-Acting P... Merck Completes Acquisition of Cidara Therapeutics to Advance Long-Acting P... Read Post »
Policy & AcquisitionsAmgen acquires Dark Blue Therapeutics to strengthen AML protein degrader pi... Amgen acquires Dark Blue Therapeutics to strengthen AML protein degrader pi... Read Post »
Policy & AcquisitionsJohnson & Johnson Finalizes Acquisition of Halda Therapeutics Johnson & Johnson Finalizes Acquisition of Halda Therapeutics Read Post »
Policy & AcquisitionsSanofi to Acquire Dynavax, Strengthening Adult Vaccine Portfolio with HEPLI... Sanofi to Acquire Dynavax, Strengthening Adult Vaccine Portfolio with HEPLI... Read Post »
Policy & AcquisitionsJohnson & Johnson Acquires Halda Therapeutics and Its RIPTAC Platform Johnson & Johnson Acquires Halda Therapeutics and Its RIPTAC Platform Read Post »
Policy & AcquisitionsPfizer Finalizes up to $10B Acquisition of Metsera after Fierce Bidding War... Pfizer Finalizes up to $10B Acquisition of Metsera after Fierce Bidding War... Read Post »
